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Abstract
Background: Over the past decades, health care services for pancreatic surgery were reorganized. Volume norms
were applied with the result that only a limited number of expert centers perform pancreatic surgery. As a result of
this centralization of pancreatic surgery, the patient journey of patients with pancreatic tumors has become multi-
institutional. To illustrate, patients are referred to a center of expertise for pancreatic surgery whereas other parts of
pancreatic care, such as chemotherapy, take place in local hospitals. This fragmentation of health care services
could affect continuity of care (COC). The aim of this study was to assess COC perceived by patients in a pancreatic
care network and investigate correlations with patient-and care-related characteristics.
Methods: This is a pilot study in which patients with (pre) malignant pancreatic tumors discussed in a multidisciplinary
tumor board in a Dutch tertiary hospital were asked to participate. Patients were asked to fill out the Nijmegen Continuity of
Care-questionnaire (NCQ) (5-point Likert scale). Additionally, their patient-and care-related data were retrieved from medical
records. Correlations of NCQ score and patient-and care-related characteristics were calculated with Spearman’s correlation
coefficient.
Results: In total, 44 patients were included (92% response rate). Pancreatic cancer was the predominant diagnosis (32%).
Forty percent received a repetition of diagnostic investigations in the tertiary hospital. Mean scores for personal continuity
were 3.55 ± 0.74 for GP, 3.29 ± 0.91 for the specialist and 3.43 ± 0.65 for collaboration between GPs and specialists. Overall
COC was scored with a mean 3.38 ± 0.72. No significant correlations were observed between NCQ score and certain patient-
or care-related characteristics.
Conclusion: Continuity of care perceived by patients with pancreatic tumors was scored as moderate. This outcome
supports the need to improve continuity of care within multi-institutional pancreatic care networks.
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Introduction
Patients suspected of pancreatic cancer go through an inten-
sive process of multiple diagnostic investigations. If diagnosis
is confirmed, they will often receive a multimodal treatment.
This process usually starts with the general practitioner (GP).
After referral to the hospital, several different medical profes-
sionals are involved, such as pancreatic surgeons, gastroen-
terologists, radiologists, medical oncologists, radiation
oncologists and dieticians. In case of advanced malignant
disease, palliative health care professionals are involved as
well. In several European countries, such as the United King-
dom and the Netherlands, volume standards apply for pan-
creatic surgery [1], leading to centralization of pancreatic
care in high-volume centers. The main rationale for this
centralization is the significant correlation between higher
hospital volume and improvement of both in-hospital mor-
tality and long-term survival [2–4]. Evidently, these better
outcomes are worth pursuing, but centralization of a part of
the patient journey also carries a risk of fragmentation of
care. Patients may undergo their initial diagnostic assessment
in a local general hospital, have consequent or repeat diag-
nostic investigations and pancreatic surgery in a center of ex-
pertise, followed by adjuvant chemotherapy and follow-up in
their local hospital. Additionally, during this patient journey,
patients often have irregular contacts with their GPs. This
multidisciplinary and multi-institutional care pathway is frag-
mented and may hamper continuity of care as experienced
by patients suspected of pancreatic cancer.
Continuity of care (COC) is defined as the degree to
which a series of healthcare events is experienced as co-
herent, connected and relevant to the patients’ medical
requirements and personal context [5] and is associated
with increased patient satisfaction, increased health-
related quality of life [6, 7], decreased use of hospital ser-
vices and reductions in mortality [8]. For these reasons,
COC can be considered an important aspect of high-
quality patient care [9, 10]. Perhaps continuity of care is
even more important for pancreatic cancer patients.
These patients generally render a poor prognosis and are
so much dependent on different care providers that they
should be able to feel assured of COC and therefore the
best possible outcomes [11].
Previous studies have evaluated the experienced
COC in different patient populations, such as oral
cancer [12], hypertension [13], and rehabilitation [14].
However, to date no study has assessed COC in pa-
tients with (pre) malignant pancreatic tumors. This is
important to assess as it may well be that the current
multidisciplinary and multi-institutional pancreatic
care services affect COC. In addition, such an assess-
ment of COC may indicate areas of improvement in
current pancreatic care.
The aim of this study is to assess COC experienced by
patients treated in a regional pancreatic care network. A
secondary aim is to investigate correlations between
COC and patient-related or care-related characteristics.
Methods
Statement of ethics
This study was approved by the medical ethics commit-
tee (protocol number 2019–5735) of the Radboud uni-
versity medical center (Radboudumc). Written informed
consent was obtained for all included patients. No exter-
nal incentives were provided.
Study design
This is a pilot study with a prospective cohort of patients
diagnosed with pancreatic tumors in a tertiary health cen-
ter in the Netherlands. This study report is in accordance
with the STROBE-guidelines (Strengthening the Reporting
of Observational Studies in Epidemiology) [15].
Setting and study population
Patients discussed in the weekly multidisciplinary tumor
board meetings (MDT) of the PACON (Pancreatic Center
East Netherlands) held between October 1, 2018 and De-
cember 31, 2018 were invited to participate. The PACON
is part of the Radboudumc, a tertiary medical center serv-
ing six affiliated general hospitals regarding pancreatic
care in the surrounding region, consisting of approxi-
mately two million inhabitants. The pancreatic care net-
work is characterized by an anchor establishment, the
Radboudumc, offering a vast array of pancreatic tumor
care services, such as pancreatic surgery, and the affiliating
hospitals, offering a more limited array of pancreatic
tumor care services, such as systemic treatment. In order
to provide appropriate care, these affiliating hospitals need
to collaborate closely with the Radboudumc and refer pa-
tients if necessary. GPs can also be considered part of the
network, as in the Netherlands they are the gatekeepers to
secondary care. If required, they refer patients to the hos-
pital and play a role during the entire disease trajectory.
Eligible patients with tumors of the pancreas, both
(pre) malignant or benign tumors, who were discussed
in the PACON between October 1, 2018 and December
31, 2018, were contacted by email between September
2019 and December 2019. Because they were referred to
the PACON a year prior, they had at least a 12-month
period to experience pancreatic care in the network. In
case of no response, patients were sent a reminder by
email and called once by a team member.
Patients aged under 18 years, those with speaking or
reading difficulties in the Dutch language, and patients
without a therapeutic relationship with a healthcare pro-
fessional of Radboudumc regarding their pancreatic
tumor, were excluded.
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Data collection
Clinical data and treatment characteristics were retrieved
from the patient’s electronic medical record. These in-
cluded sex, age, time of referral, referring center and dis-
cipline, type and number of diagnostic investigations in
the diagnostic phase in the referring center and in the
tertiary center. A repetition of diagnostics was defined as
a repeat diagnostic investigation in the tertiary center
within 5 months after the same diagnostic investigation.
Furthermore, number of MDTs, MDT advice, type of
treatment, start of treatment, number of consultations,
either at the outpatient clinic or by telephone, were re-
trieved. Number of consultations are considered up until
1 April 2019.
Nijmegen continuity of care questionnaire (NCQ)
The NCQ is an instrument that measures COC experi-
enced by patients in primary and secondary care settings
[16, 17]. It comprises 28 items divided into two subdo-
mains: ‘personal continuity’ and ‘team/cross-boundary
continuity’. The assessment of personal continuity in-
volves 16 questions concerning the relationship with the
patient’s health care provider, i.e. the general practitioner
and the most important medical specialist, as determined
by the patient. This personal continuity assesses the pa-
tient’s perception of how well the care provider knows the
patient and how committed the care provider is. The sec-
ond domain assesses ‘team/cross-boundary continuity’
with 12 questions, indicating the patient’s perceived COC
throughout the team of primary care, the team of special-
ized hospital care and the cooperation between these two.
Each question can be answered on a 5-point Likert scale
ranging from 1 (“strongly disagree”), 2 (“disagree”), 3
(“neutral”), 4 (“agree”) to 5 (“strongly agree”), or with “?”
(“I do not know”). Each subscale eventually has a mean
score. NCQ-scores below 2 are interpreted as low, a mean
score of 3 as moderate and mean scores of 4 or higher as
high continuity of care. Additional file 1: Appendix A
shows the full questionnaire. The questionnaire is consid-
ered a reliable, comprehensive instrument that measures
COC as a multidimensional concept, regardless of comor-
bidity or care setting. It has been validated in primary care
and secondary care, as well as in other languages [12, 13,
18]. To adequately assess COC, patients should have had
contact with a GP or medical specialist in the previous
year. The NCQ was developed to enable baseline mea-
surements in the evaluation of interventions aiming for
improved COC.
In this study, patients received a secured email providing
access to the online questionnaire. After finalizing the
questionnaire, patients were given the opportunity to
write down additional remarks in a blank box. The NCQ-
questionnaire was used in the original Dutch language
and was not adjusted.
Reliability of the NCQ-questionnaire for patients with
pancreatic tumors
Since the NCQ was used in its original version, a factor
analysis with content and construct validity as done by
the original study [16] was deemed unnecessary. How-
ever, to indicate the robustness of the NCQ for the pan-
creatic tumor population, reliability was tested with the
calculation of Cronbach’s alfa. Cronbach’s alfa indicates
the reliability of questionnaire-items, in which alfa values
> 0.8 indicate good reliability [19]. In addition, the num-
bers and percentages of patients with the highest and
lowest score possible (ceiling and floor effects) were pre-
sented and compared to the floor and ceiling effects as
observed by the original study. Floor and ceilings effects
are considered to be present if > 15% of the respondents
score the highest or lowest score possible [20]. With the
Cronbach’s alfa and trends in ceiling and floor effects,
the reliability and usefulness of this questionnaire for the
pancreatic tumor population was determined.
Statistical analysis
Data was analyzed using SPSS version 25 (SPSS Inc.,
Chicago, IL, USA). Descriptive data was presented as
mean and standard deviation (SD) or median and range
as appropriate. Categorical variables were expressed in
numbers and percentages. NCQ-item scores were
expressed in item means, SD and subscale scores. Pa-
tients who answered the first subscale item with ‘this
subscale is not applicable to me’ and patients who an-
swered a subscale item with ‘I do not know’ or ‘?’ were
reported as missing rates. We reported the number of
missing values per item and we did not compensate for
missing values by imputation. A minimum of three items
per subscale were required to be filled out for being con-
sidered in the analyses. Differences between GPs and
medical specialists concerning mean NCQ scores were
calculated using a Paired Samples T-test. Correlations
between NCQ scores and patient characteristics were
calculated with a Spearman’s correlation coefficient. Dif-
ferences in baseline characteristics between patients with
insufficient (< 3) and sufficient NCQ score (≥3) groups
were calculated with a Mann-Whitney U test. P-values
< 0.05 were considered statistically significant.
Results
Between October 2018 and December 2018, 128 patients
were discussed in the MDT of the PACON. Of these, 84
met the inclusion criteria and were approached to par-
ticipate. Forty-eight patients gave informed consent, 19
patients did not respond and 17 patients declined study
participation for various reasons (e.g. seriousness of dis-
ease, lack of personal benefit or because of dissatisfac-
tion regarding their patient journey). Of the 48 patients
who gave informed consent, 44 patients completed the
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questionnaires (92% response rate). Figure 1 depicts a
flow diagram.
Patient characteristics
Table 1 shows the baseline characteristics of the study
population. The respondents had a mean age of 68 years,
the majority were patients with a new diagnosis (68.2%)
and male (65.9%). Pancreatic cancer was the predomin-
ant diagnosis in the cohort of NCQ respondents (31.8%),
followed by the pancreatic cystic neoplasms (20.5%) and
benign tumors due to chronic pancreatitis (20.5%). In
the total cohort discussed in the MDT between October
2018 and December 2018 (n = 128) pancreatic cancer
(63.3%) was the predominant diagnosis as well, followed
by chronic pancreatitis (10.9%). Patients were referred to
the PACON from nine different hospitals. In addition,
one patient was referred directly by a GP and one pa-
tient was referred from a different department within
the Radboudumc. Most patients were referred by a
gastroenterologist (79.5%). A considerable proportion of
the diagnostic investigations in the tertiary center was a
repetition of earlier performed diagnostic investigations
of the same modality in the referring hospital. For in-
stance, of all patients receiving an abdominal CT-scan in
the tertiary center, 42% had already received a prior CT-
scan in the referring center. Considering the location of
treatment and follow-up, the majority of patients re-
ceived treatment and follow-up in the tertiary center or
a combination of tertiary center and referring center.
Reliability of NCQ
Floor effects were not observed. Ceiling effects were ob-
served in three items for the GP and two items for the
specialist, both in subscale 1 (Table 2). For example, the
item “This care provider knows my medical history very
well” was scored with 5 (1–5) by 18.2% of the patients for
the GP and 22.7% of the patients for the specialist. The
subscales of the NCQ appeared to have good internal con-
sistencies for both personal continuity (Cronbach’s α =
0.91) and cross-boundary continuity (α = 0.93), as both
subitems have a Cronbach’s alfa > 0.8. The Cronbach’s alfa
did not increase with the removal of certain subscale
items, indicating that all items were valuable to the
questionnaire.
The Nijmegen continuity of care questionnaire (NCQ)
In Tables 2 and 3 all mean scores are presented. The total
mean NCQ score was 3.38 ± 0.72 (scale 1–5). Mean scores
Fig. 1 Flowchart of the total cohort and included patients
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for personal continuity were higher for the GP than for
the specialist (3.55 vs 3.29) and mean scores for cross-
boundary continuity were higher for the specialist (3.66 vs
3.49), but these differences were not statistically signifi-
cant. COC experienced in collaboration between GPs and
specialists was ranked with 3.43 ± 0.65. Thirteen patients
(29%) had a mean NCQ score below three. One of these
patients had an additional remark concerning hospital
care: “I have good experiences in one department, but the
other department did not show commitment and did in-
sufficiently read my medical record. For example, they did
not read the treatment plan I had made with my other
specialist, which led to mistakes.” Notably, more questions
in subscale 3. were answered with ‘?’ or were missing com-
pared to questions for subscale 1. and 2. Subscale 3 items
concerning the collaboration within the hospital were an-
swered by approximately 65% of all respondents whereas
items concerning collaboration within primary care were
answered by 46% of all respondents.
COC and correlated parameters
There were no significant correlations observed between
mean NCQ scores and patient- and care-related charac-
teristics such as diagnosis, age, number of MDT meet-
ings, outpatient visits or the repetition of diagnostics.
Additionally, no significant differences were observed
between patients with an insufficient or sufficient NCQ
scores (< 3 or ≥ 3) concerning these characteristics.
Discussion
This study assessed the continuity of care experienced
by patients in a regional pancreatic care network and in-
vestigated possible correlations between COC and pa-
tient- and care-related characteristics.
Overall COC was scored with a mean 3.38 ± 0.72,
which indicates that patients with pancreatic tumors in
our pancreatic care network perceive COC as moderate.
Mean score for personal continuity for the GP and the
specialist were 3.55 ± 0.74 and 3.29 ± 0.91. Mean scores
for COC in collaboration within primary care, within the
hospitals and between these institutes were 3.49 ± 0.68,
3.66 ± 058 and 3.43 ± 0.65. No significant differences
were observed in total scores between GPs and special-
ists and no significant correlations were observed be-
tween NCQ score and certain patient-related or care-
related characteristics.
Comparing these results with the study by Uijen et al.
(2011), the authors who developed the NCQ, several
similarities and differences can be seen [16]. Similarly to
our findings, as we observed higher missing rates for
team/cross boundary continuity (35–38%) compared to
personal continuity, Uijen et al. also describe high miss-
ing rates for the questionnaire items concerning team/
cross boundary continuity (25–26%). These findings sug-
gest that patients are more hesitant to answer this type
of questions because they are not aware or informed
about the collaboration within or between these care
providers. However, in contrast with the Uijen et al., our
study reports higher missing rates for the items concern-
ing collaboration within primary care than for the
Table 1 Baseline characteristics of study population (n = 44)
Patient Characteristic n (%)a
Age, yrs. (mean ± sd) 67.8 ±
9.1
Male sex 29 (65.9)
Patients with new diagnosis 30 (68.2)
Diagnosis
Pancreatic carcinoma 12 (27.3)
Metastatic pancreatic cancer 2 (4.5)
pNET 3 (6.8)
Pancreatic cystic neoplasms 9 (20.5)
Bile duct cancer/ Ampullary carcinoma 4 (9.1)
Chronic pancreatitis 9 (20.5)
Other (e.g. metastases from elsewhere) 6 (13.6)
Number of MDTs per patient (mean ± sd) 2.0 ± 1.1
Repetition of CT-scan by tertiary center (PACON) 8 (42)
Repetition of MRI-scan by tertiary center (PACON) 12 (37.5)
Repetition of endoscopy by tertiary center (PACON) 4 (25)
Time (days) between diagnosis and treatment plan by






Neoadjuvant treatment with surgery 3 (6.8)
Surgery with adjuvant chemotherapy 6 (13.6)
Chemotherapy 1 (2.3)
Other 8 (18.2)
No treatment or no follow up indicated 2 (4.5)
Location of treatment
Tertiary center (PACON) 25 (56.8)
Referring hospital 4 (9.1)
Combination of PACON and referring hospital 7 (15.9)
Unknown/other 8 (18.2)
Outpatients visits to specialist tertiary center (mean ± sd) 3.15 ±
2.65
Phone consultation with specialist tertiary center (mean ± sd) 2.23 ±
1.50
Abbreviations: pNET pancreatic neuroendocrine tumor, MDT Multidisciplinary
team meeting, PACON Pancreatic Center East Netherlands (part of tertiary
health center)
aunless specified otherwise in patient characteristic. bFollow-up patients
were excluded
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collaboration within hospital care. This could suggest
that patients included in this study perceived items con-
cerning the collaboration within primary care to a lesser
extent applicable to them. A possible explanation for this
is that the GP was less involved in their care process
compared to the patient population studied by Uijen
et al., which consisted of patients with hypertension,
diabetes mellitus type 2 and COPD. Considering floor
and ceiling effects, it is noteworthy that a larger propor-
tion of patients reported high scores for personal con-
tinuity of the specialist compared to the scores described
in the original article. For instance, “This care provider
always remembers what he/she did during my last visit”
was scored the highest possible score by 18% of this
Table 2 Personal continuity experienced by patients in a regional pancreatic care network, concerning GP and most important




















Subscale 1: personal continuity: care provider knows me
a. I know this care provider very well 3.81
(0.86)
8 (18) 0 (0) 8 (18.2) 3.28 4 (9) 3 (6.8) 1 (2.3)




8 (18) 0 (0) 8 (18.2) 3.92 7 (16) 0 (0) 10 (22.7)
c. This care provider always remembers what he/
she did during my last visit(s)
3.86
(0.81)
9 (20) 0 (0) 7 (15.9) 3.81 7 (16) 1 (2.3) 8 (18.2)




8 (18) 1 (2.3) 5 (11.4) 2.92 5 (11) 6 (13.6) 2 (4.5)




9 (20) 1 (2.3) 2 (4.5) 3.00 6 (14) 5 (11.4) 0 (0)
Subscale 2: personal continuity: care provider shows commitment
f. This care provider contacts me if it is needed, I do
not have to ask
3.36
(1.13)
8 (18) 0 (0) 6 (13.6) 3.38 7 (16) 2 (4.5) 4 (9.1)
g. This care provider knows very well what I believe
is important in my care
3.39
(1.09)
11 (25) 2 (4.5) 4 (9.1) 3.37 6 (14) 4 (9.1) 3 (6.8)
h. This care provider keeps in contact sufficiently
when I see other care providers
3.26
(0.99)
10 (23) 2 (4.5) 2 (4.5) 3.08 6 (14) 3 (6.8) 1 (2.3)
Mean score 3.55 (0.74) 3.29 (0.91)
Table 3 Continuity of care experienced by patients in a regional pancreatic care network in collaboration between care providers





































Subscale 3: Cross-boundary continuity
1. These care providers transfer




22 (50) 1 (2.3) 1 (2.3) 3.76
(0.51)
15 (34) 0 (0) 1 (2.3) 3.64
(0.73)
16 (36) 0 (0) 3 (6.8)




24 (55) 0 (0) 1 (2.3) 3.71
(0.60)
16 (36) 0 (0) 1 (2.3) 3.44
(0.64)
17 (38) 0 (0) 0 (0)
3. The care of these care




24 (55) 0 (0) 0 (0) 3.76
(0.69)
15 (34) 0 (0) 3 (6.8) 3.41
(0.78)
17 (38) 0 (0) 1 (2.3)
4. These care providers always
know very well from each
other what they do
3.32
(0.82)
25 (57) 1 (2.3) 0 (0) 3.43
(0.84)
16 (36) 0 (0) 2 (4.5) 3.15
(0.78)
18 (41) 0 (0) 1 (2.3)
Mean score 3.49 (0.68) 3.66 (0.58) 3.43 (0.65)
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study population, while Uijen et al. report this to be 5%.
This difference suggests that personal COC provided by
the specialist was better evaluated by pancreatic tumor
patients than the patient population included in Uijen
et al. This difference is, however, quite conceivable con-
sidering pancreatic tumors are rare for a GP and the
diagnostic and treatment process, in contrast to hyper-
tension, diabetes mellitus type 2 and COPD, generally
takes place in the hospital. Other differences in floor and
ceiling effects between these studies were not observed.
Considering the absence of large floor and ceiling effects
and the high internal consistence observed in this study
(Cronbach’s alpha > 0.9), we have shown that the NCQ
is a reliable and useful tool to measure COC experienced
by patients in a regional pancreatic care network.
This study has several limitations. Firstly, this study
has a low sample size. This is partially due to the ex-
plorative character of the study. We intended to quanti-
tatively measure how COC was experienced by patients
in our network as we learned from some patient inter-
views that COC was experienced as suboptimal. In order
to assess this, we aimed to include approximately 50 pa-
tients from our total cohort to fill out the NCQ. We
considered this to be an adequate number of patients for
gaining insight in the experienced COC, and to test
whether the NCQ was a reliable tool to assess COC in
patients with pancreatic tumors. Another reason for the
low sample size, is that a substantial number of patients
in our cohort died over the follow-up period and became
ineligible for study participation. A one-year follow-up
period was required for COC to be adequately evaluated.
Because of this low sample size, the lack of observed
correlations between NCQ scores and certain patient
characteristics should be interpreted with caution. Espe-
cially since other studies with larger sample sizes have
described correlations between continuity of care and
patient characteristics such as sex, diagnosis or number
of outpatient visits [12, 13, 21]. Therefore, there is the
possibility a type II error occurred. To circumvent the
problem of a low sample size that may occur when pa-
tient experiences need to be collected as a measure of
COC, several studies have suggested to use medical re-
cords or national insurance data to derive insight in
COC [22–24]. From these data certain parameters, such
as the total number of providers, total number of patient
visits or the number of handoffs of information, can be
derived. Subsequently, these parameters may serve in a
COC index, such as the Usual Provider of Care, the
Bice-Boxerman Continuity of Care Index, Sequential
Continuity Index or the Herfindahl-Hirschman index
[22, 25–27]. Though this would indeed not require par-
ticipation of patients or exhaustive data collection, these
quantitatively derived indices have restrictions. They
only measure one component of COC and some,
especially those indices focusing on the proportion of
visits where the patient saw the same care provider, do
not take into account aspects such as a change of GP
due to intentional reasons or multiple care providers
due to multimorbidity [28]. It seems more sensible to
determine COC by measuring the experience of those
that actually receive care – the patients. Therefore, we
believe that establishing the patients’ perspective on
COC is most appropriate for establishing COC. Using a
patient-centered measure of COC could also be per-
ceived as a strength. In addition to the low sample size,
a second limitation concerns the representativeness of
the study. Pancreatic cancer was the predominant diag-
nosis in both cohorts, however, in the total cohort dis-
cussed in the MDT between October 2018 and
December 2018 twice as many patients had pancreatic
cancer (63%) as in the cohort of NCQ respondents
(32%). This difference can be partially attributed to the
deaths of patients with pancreatic cancer after 1 year.
The underrepresentation of patients with pancreatic
cancer makes the respondents cohort less representative
for the total patient population with pancreatic tumors.
On the other hand, the group of respondents is a true
representation of the population that is alive 1 year after
discussion in an MDT. A third limitation concerns non-
response bias. Non-response bias plays a role as 20% of
the approached patients declined participation because
of several reasons, of which one was dissatisfaction with
current care. The valuable input from this patient cat-
egory is not reflected in our study results.
A strength of this study is that it is the first to describe
COC as perceived by patients with pancreatic tumors in
a pancreatic care network. Additionally, we have shown
that the NCQ is a reliable questionnaire for this patient
population. As personal and cross-boundary continuity
were evaluated both for primary and hospital care, a
comprehensive evaluation of COC for pancreatic tumor
patients is obtained, revealing new information in the
domain of overall quality of care for this patient popula-
tion. Considering very limited studies have focused on
quality of care and health services research for patients
with pancreatic tumors [29], this study makes a valuable
contribution.
Because COC is experienced as only moderate in pa-
tients with suspected pancreatic cancer, improvement of
COC deserves attention. The extremely low five-year
survival rates of pancreatic cancer patients [11], empha-
sizes the relevance of quality of life and quality of care
for this patient population. The results of this study sup-
port the urge for coherent and better connected care. In
addition, the complexity of managing pancreatic tumor
patients in a multi-institutional network is illustrated in
this study. Almost 20% the respondents received treat-
ment concerning their pancreatic tumor in both the
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general hospital and the tertiary center simultaneously.
Two in five patients undergoing a diagnostic investiga-
tion in the tertiary center, such as endoscopy, a CT or
MRI-scan, had already undergone this investigation in
the referring hospital. Reasons for repetition were not
monitored but could consists of an inadequate primary
scan (i.e. wrong protocol) or loss of actuality due to
delay. We suspect that if collaboration within this multi-
institutional network were to be improved, unnecessary,
invasive and costly repeat-diagnostic procedures could
be avoided. However, studies are needed to test this
hypothesis.
In literature, several interventions are described to
improve COC experienced by patients with multiple
care providers. Some suggest the MDT is best able to
coordinate care and ensure continuity of patient care
and that the involvement of a GP in the MDT, for
instance by means of video call, may lead to better
coordination and continuity of care [30, 31]. Others
propose joint consultations with GPs, oncologists and
the patient [32]. Empirical studies are momentarily
lacking but the effect of these joint consultations on
continuity of care is currently being studied in a Da-
nish RCT [33]. Another possible intervention could
be found in the direction of eHealth and digital care
platforms [34]. Such a platform may enable care pro-
viders from multiple institutes to exchange important
patient-related information, offer patients e-
consultations and allow patients easy access in view-
ing their current treatment trajectory, appointments,
and diagnostic results. Though most studies involving
these platforms have a short follow-up and low sam-
ple size, the preliminary results are promising in
terms of feasibility and acceptability [34]. It seems
reasonable that these platforms may bridge the gaps
between primary, secondary and tertiary health care
and aid in making the health care services for pa-
tients with pancreatic tumors more streamlined, con-
tinuous and of high-quality. Future studies are
necessary to study this hypothesis.
Conclusion
Continuity of care perceived by patients with pancreatic
tumors in our multi-institutional network was perceived
as moderate. No correlations between patient- or care-
related characteristics and continuity of care were ob-
served. The moderate outcome of the perceived COC
underlines the necessity to improve current COC experi-
enced during the patient journey by for instance improv-
ing health care services. We advocate for investments by
health care providers involved in the treatment of pa-
tients with pancreatic tumors to investigate possible
means to improve current COC provided in a multi-
institutional network.
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